Indication
Macrophage activation syndrome
Macrophage activation syndrome is a life-threatening, hyperinflammatory state categorized as a secondary form of hemophagocytic lymphohistiocytosis. Read more about Macrophage activation syndrome
2 drugs 2 manufacturers
Drugs that treat it
Common Macrophage activation syndrome therapies.
GAMIFANT (emapalumab-lzsg)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMacrophage activation syndrome is a life-threatening, hyperinflammatory state categorized as a secondary form of hemophagocytic lymphohistiocytosis.
It predominantly complicates pediatric and adult autoimmune or autoinflammatory conditions, most notably systemic juvenile idiopathic arthritis, Adult-onset Still's disease, and systemic lupus erythematosus.
Pathophysiologically, it is driven by defective cytotoxic cell function and the uncontrolled activation and expansion of T lymphocytes and macrophages, producing a massive cytokine storm and widespread hemophagocytosis.
Clinically, the syndrome manifests as persistent high fevers, hepatosplenomegaly, lymphadenopathy, cytopenias, marked hyperferritinemia, coagulopathy, hepatic dysfunction, and potential multiorgan failure.
- nih.gov
Macrophage activation syndrome is a life-threatening, hyperinflammatory state categorized as a secondary form of hemophagocytic lymphohistiocytosis
- nih.gov
Macrophage activation syndrome is a life-threatening, hyperinflammatory state categorized as a secondary form of hemophagocytic lymphohistiocytosis Pathophysiologically, it is driven by defective cytotoxic cell function and the uncontrolled activation and expansion of T lymphocytes and macrophages, producing a massive cytokine storm and widespread hemophagocytosis
- nih.gov
It predominantly complicates pediatric and adult autoimmune or autoinflammatory conditions, most notably systemic juvenile idiopathic arthritis, Adult-onset Still's disease, and systemic lupus erythematosus Clinically, the syndrome manifests as persistent high fevers, hepatosplenomegaly, lymphadenopathy, cytopenias, marked hyperferritinemia, coagulopathy, hepatic dysfunction, and potential multiorgan failure
- nih.gov
It predominantly complicates pediatric and adult autoimmune or autoinflammatory conditions, most notably systemic juvenile idiopathic arthritis, Adult-onset Still's disease, and systemic lupus erythematosus
- nih.gov
It predominantly complicates pediatric and adult autoimmune or autoinflammatory conditions, most notably systemic juvenile idiopathic arthritis, Adult-onset Still's disease, and systemic lupus erythematosus
- nih.gov
Pathophysiologically, it is driven by defective cytotoxic cell function and the uncontrolled activation and expansion of T lymphocytes and macrophages, producing a massive cytokine storm and widespread hemophagocytosis Clinically, the syndrome manifests as persistent high fevers, hepatosplenomegaly, lymphadenopathy, cytopenias, marked hyperferritinemia, coagulopathy, hepatic dysfunction, and potential multiorgan failure
- merckmanuals.com
Clinically, the syndrome manifests as persistent high fevers, hepatosplenomegaly, lymphadenopathy, cytopenias, marked hyperferritinemia, coagulopathy, hepatic dysfunction, and potential multiorgan failure
Personalize your experience
Follow Macrophage activation syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.